Quest Diagnostics Ownership
DGX Stock | USD 166.62 0.96 0.58% |
Quest |
Quest Stock Ownership Analysis
About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 61.06. The company has Price/Earnings To Growth (PEG) ratio of 1.5. Quest Diagnostics recorded earning per share (EPS) of 7.69. The entity last dividend was issued on the 7th of April 2025. The firm had 2:1 split on the 21st of June 2005. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people. To learn more about Quest Diagnostics Incorporated call Stephen Rusckowski at (973) 520-2700 or check out https://www.questdiagnostics.com.Quest Diagnostics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quest Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quest Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Quest Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Delaney Mark E over a month ago Acquisition by Delaney Mark E of tradable shares of Quest Diagnostics at 158.025 subject to Rule 16b-3 | ||
Michael Prevoznik over three months ago Disposition of 35146 shares by Michael Prevoznik of Quest Diagnostics at 86.63 subject to Rule 16b-3 | ||
Karthik Kuppusamy over three months ago Disposition of 1775 shares by Karthik Kuppusamy of Quest Diagnostics at 156.9156 subject to Rule 16b-3 | ||
Michael Deppe over six months ago Disposition of tradable shares by Michael Deppe of Quest Diagnostics at 125.02 subject to Rule 16b-3 | ||
Sam Samad over six months ago Disposition of 656 shares by Sam Samad of Quest Diagnostics at 126.36 subject to Rule 16b-3 | ||
John Ziegler over a year ago Sale by John Ziegler of 1953 shares of Quest Diagnostics |
Quest Diagnostics' latest congressional trading
Congressional trading in companies like Quest Diagnostics, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Quest Diagnostics by those in governmental positions are based on the same information available to the general public.
2025-02-12 | Representative Gil Cisneros | Acquired Under $15K | Verify | ||
2024-12-06 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2024-02-13 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
2024-01-02 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Quest Diagnostics Outstanding Bonds
Quest Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Quest Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Quest bonds can be classified according to their maturity, which is the date when Quest Diagnostics Incorporated has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
QUEST DIAGNOSTICS INC Corp BondUS74834LAX82 | View | |
QUEST DIAGNOSTICS INC Corp BondUS74834LAZ31 | View | |
US74834LAY65 Corp BondUS74834LAY65 | View | |
QUEST DIAGNOSTICS INCORPORATED Corp BondUS74834LBB53 | View | |
US74834LBA70 Corp BondUS74834LBA70 | View | |
US74834LBC37 Corp BondUS74834LBC37 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.